- Home
- ENGN vs SPOK Comparison
ENGN vs SPOK Comparison
Compare ENGN & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- SPOK
- Stock Information
- Founded
- ENGN 1999
- SPOK 2004
- Country
- ENGN Canada
- SPOK United States
- Employees
- ENGN N/A
- SPOK N/A
- Industry
- ENGN
- SPOK Telecommunications Equipment
- Sector
- ENGN
- SPOK Telecommunications
- Exchange
- ENGN Nasdaq
- SPOK Nasdaq
- Market Cap
- ENGN 297.7M
- SPOK 318.9M
- IPO Year
- ENGN N/A
- SPOK 1992
- Fundamental
- Price
- ENGN $3.39
- SPOK $16.54
- Analyst Decision
- ENGN Buy
- SPOK Hold
- Analyst Count
- ENGN 7
- SPOK 1
- Target Price
- ENGN $23.29
- SPOK $15.00
- AVG Volume (30 Days)
- ENGN 54.9K
- SPOK 180.4K
- Earning Date
- ENGN 06-13-2025
- SPOK 04-30-2025
- Dividend Yield
- ENGN N/A
- SPOK 7.54%
- EPS Growth
- ENGN N/A
- SPOK N/A
- EPS
- ENGN N/A
- SPOK 0.77
- Revenue
- ENGN N/A
- SPOK $139,038,000.00
- Revenue This Year
- ENGN N/A
- SPOK $2.26
- Revenue Next Year
- ENGN N/A
- SPOK $0.14
- P/E Ratio
- ENGN N/A
- SPOK $21.51
- Revenue Growth
- ENGN N/A
- SPOK N/A
- 52 Week Low
- ENGN $3.27
- SPOK $13.55
- 52 Week High
- ENGN $14.67
- SPOK $17.96
- Technical
- Relative Strength Index (RSI)
- ENGN 27.30
- SPOK 59.93
- Support Level
- ENGN $3.51
- SPOK $13.55
- Resistance Level
- ENGN $3.99
- SPOK $16.60
- Average True Range (ATR)
- ENGN 0.40
- SPOK 0.61
- MACD
- ENGN -0.00
- SPOK 0.21
- Stochastic Oscillator
- ENGN 10.71
- SPOK 95.22
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.